JOLT — Jolt Health Cashflow Statement
0.000.00%
- CA$0.57m
- CA$0.67m
Annual cashflow statement for Jolt Health, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 September 30th | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.325 | -9.52 | -3.58 | -0.766 | -1.17 |
Amortisation | |||||
Non-Cash Items | 0.197 | 7.88 | 1.93 | 0.43 | 0.272 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.054 | 0.193 | 0.142 | 0.214 | 0.393 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -0.183 | -1.41 | -1.5 | -0.122 | -0.505 |
Capital Expenditures | — | -0.161 | — | — | — |
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -0.352 | -0.008 | -0.81 | 0 | -0.01 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.352 | -0.169 | -0.81 | 0 | -0.01 |
Financing Cash Flow Items | — | — | — | -0.017 | -0.015 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.54 | 1.38 | 2.02 | 0.083 | 0.514 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.006 | -0.196 | -0.293 | -0.04 | -0.001 |